Market Research Logo

Parallel Trade

SMi's premier 11th Annual Parallel Trade for Pharma returns to London on 6-7 Feb 2017 after 10 successful years in the running!

According to the European Federation of Pharmaceutical Industries and Associations, parallel trade was estimated to amount to € 5,589 million (value at ex–factory prices) in 2014. The fragmentation of the EU pharmaceutical market has resulted in a lucrative year for parallel trade. Factors such as foreign exchange fluctuations and legal battles on trademarks and counterfeit medicines are continuously shifting the European market dynamics.

With Brexit and the new EU Falsified Medicine Directive, what does the future hold for parallel trade? This event will discuss short term versus long term concerns of pharma manufacturers, regulators, as well as parallel traders. They will engage in an interactive debate and discuss how to keep abreast of the current trends and how to overcome all challenges. Discussion topics include:

Parallel Trade 101 - Which factors determine the flow of pharmaceutical products in Europe?
The European Commission’s Falsified Medicines Directive – recent updates
Panel Debate – In the spotlight: Shortages
The Patient’s perspective
Parallel traders panel – challenges and opportunities
Beyond pharmaceutical products – parallel imports of medical devices
Panel Debate - In the spotlight: Technology & new trends
Regional and country focus - Scandinavia, Germany, the UK, Central and Eastern Europe, Turkey and Eurasia
This is the only industry meeting with 80+ selected senior leaders in parallel trade to discuss upcoming trends and share best practices. Join us today to keep abreast and stay ahead of competition!


Day 1
8:30
Registration & Coffee
9:00
Chairman's Opening Remarks
Eric Noehrenberg , Director, Regional Market Access Lead, Latin America, Shire Pharmaceuticals Group Plc
9:10
OPENING ADDRESS: Parallel Trade 101 - Which factors determine the flow of pharmaceutical products in Europe?
Eric Noehrenberg , Director, Regional Market Access Lead, Latin America, Shire Pharmaceuticals Group Plc
9:50
The European Commission’s Falsified Medicines Directive – recent updates
Richard Greville, Director Wales and Director Distribution & Supply, The Association of the British Pharmaceutical Industry
10:30
Morning Coffee
11:00
Initiatives of Parallel Distributors in the context of Falsified Medicines Directive
Tomasz Dzitko, President, Delfarma
11:40
European Medicines Verification Organization – an update from Brussels
Heinz Kobelt, Director European Affairs, European Association of Euro-Pharmaceutical Companies
12:20
Networking Lunch
13:30
Panel Debate – In the spotlight: Shortages
Tomasz Dzitko, President, Delfarma
13:30
Panel Debate – In the spotlight: Shortages
Heinz Kobelt, Director European Affairs, European Association of Euro-Pharmaceutical Companies
14:10
Country focus: Germany – the changing dynamics
14:50
Northern Europe – opportunities and challenges
Flemming Wagner, CEO, Abacus Medicine
15:30
Afternoon Tea
15:50
Region focus: Eurasia
Alexey Savin, Principal Russia and CIS, IMS Health
16:30
Legal 101 - IP, competition and regulatory law
Kathy Osgerby, Associate, Arnold & Porter
16:30
Legal 101 - IP, competition and regulatory law
Karoline Zwierzynska, Associate, Arnold & Porter
17:10
Chairman's Closing Remarks and Close of Day One
Day 2
9:00
Chairman's Opening Remarks
Eric Noehrenberg , Director, Regional Market Access Lead, Latin America, Shire Pharmaceuticals Group Plc
9:10
PANEL DEBATE: The big question - what will Brexit mean for parallel trade to and from the UK?
Andrew Stainthorpe, Director Market Access and Managed Entry, Research Health
9:50
European parallel trade – past, present and future
Shabnam Hanassab, Senior Consultant, IMS Health
10:30
Morning Coffee
10:50
The case against parallel trade in the EU – will the UK end parallel trade
Dermot Glynn, Senior Advisor, Europe Economics
11:30
Parallel traders panel – challenges and opportunities
Flemming Wagner, CEO, Abacus Medicine
11:30
Parallel traders panel – challenges and opportunities
Maarten Kamphuis, Business Development Director, FisherFarma
12:20
Networking Lunch
13:30
Beyond pharmaceutical products – parallel imports of medical devices
Katarzyna Kolasa, Science Ph.D, Warsaw Medical University
14:10
Fighting fakes by raising public awareness – how to change consumer behaviours
Mike Isles, Executive Director, European Alliance for Access to Safe Medicines
14:50
Managed entry schemes, HTA and parallel trade
Andrew Stainthorpe, Director Market Access and Managed Entry, Research Health
15:30
Afternoon Tea
16:00
Recap of the 2016 Meeting - Ask the Panel and Audience
Eric Noehrenberg , Director, Regional Market Access Lead, Latin America, Shire Pharmaceuticals Group Plc
16:30
Chairman’s Closing Remarks and Close of Day Two

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report